Budesonide
Who holds supplier records for Budesonide? 28 organisations hold a current record for Budesonide: an active US FDA Type II Drug Master File or a CEP. 20 of them hold a valid EU Certificate of Suitability (21 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (8), China (5), Italy (4), Netherlands (2) and 5 other countries (5); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Budesonide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/budesonide
Reading the evidence
- 28 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 15 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Budesonide expires 23 Jan 2043. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (28)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Budesonide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 25629, 19528 · latest filing Dec 2011
- Farmabios S.p.A.ItalyCEP Company GMP cert on recordActive DMF 15298, 25615, 13013 +1 · latest filing Dec 2011
- TAPI NL BVNetherlandsCEPActive DMF 16932, 10976 · latest filing Oct 2003
- BREATHGREEN PHARMACEUTICAL CO LTDActive DMF 38373, 39691 · latest filing Mar 2024
- AARTI PHARMALABS LIMITEDIndiaCEPActive DMF 20609 · latest filing Jun 2007
- ASPEN OSS BVNetherlandsCEP Company GMP cert on recordActive DMF 10493 · latest filing Sept 1993
- Aurisco Pharmaceutical Co.,ltdChinaCEP Company GMP cert on recordActive DMF 41233 · latest filing Jan 2025
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 27461 · latest filing Mar 2014
- CORAL DRUGS PVT LTDIndiaCEP Company GMP cert on recordActive DMF 30534 · latest filing Feb 2017
- HENAN LIHUA PHARMACEUTICAL CO LTDCEPActive DMF 35859 · latest filing Sept 2021
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChinaCEP Company GMP cert on recordActive DMF 34268 · latest filing Oct 2019
- INDUSTRIALE CHIMICA SRLItalyCEP Company GMP cert on recordActive DMF 15877, 20010 · latest filing Nov 2006
- MINAKEMFranceCEPActive DMF 28441 · latest filing Jun 2014
- NEWCHEM SPAItalyCEP Company GMP cert on recordActive DMF 25319 · latest filing Aug 2011
- STERLING SPAItalyCEP Company GMP cert on recordActive DMF 22641 · latest filing Mar 2009
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 26445 · latest filing Sept 2013
- TIANJIN TIANYAO PHARMACEUTICALS CO LTDChinaCEPActive DMF 32195 · latest filing Oct 2017
- VAMSI LABS LTDIndiaCEP Company GMP cert on recordActive DMF 43806 · latest filing Apr 2026
- Amphastar Nanjing PharmaceuticalsChinaActive DMF 33714 · latest filing Aug 2019
- Apotex Inc.CanadaActive DMF 27451 · latest filing Nov 2013
- AstraZeneca Pharmaceuticals LPUSA Company GMP cert on recordActive DMF 33171 · latest filing Oct 2018
- CHEMO IBERICA SAActive DMF 39504 · latest filing Apr 2024
- SHANDONG RISEN-SUN PHARMACEUTICAL CO LTDActive DMF 44209 · latest filing May 2026
- SYMBIOTEC PHARMALAB PRIVATE LTDIndia Company GMP cert on recordActive DMF 44046 · latest filing Apr 2026
- XUZHOU WANBANG JINQIAO PHARMA CO LTDChinaActive DMF 44469 · latest filing Sept 2026
- FinlandCEP Company GMP cert on record
- SHAKTI LIFESCIENCE PRIVATE LIMITEDIndiaCEP
- AVIK PHARMACEUTICAL LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (21)
Certificates of Suitability on the EDQM register for Budesonide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 33 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| STERLING S.p.A. Corciano | IT | CEP 2017-138 - Rev 06 Budesonide, Codes 201680 and 2016112 | Sept 2026 | Inspected Dec 2025 Italy |
| AURISCO PHARMACEUTICAL CO., LTD. Tiantai | CN | CEP 2025-046 - Rev 01 Budesonide, Micronised | Jul 2026 | Inspected Dec 2023 Germany |
| CURIA SPAIN S.A.U. Boecillo | ES | CEP 2009-037 - Rev 03 Budesonide, Sterile | Jul 2026 | Inspected Feb 2026 Spain |
| AVIK PHARMACEUTICAL LIMITED Vapi | IN | CEP 2014-177 - Rev 01 Budesonide | Jul 2026 | — |
| VAMSI LABS LIMITED Solapur | IN | CEP 2024-441 - Rev 01 Budesonide, Micronised | Jul 2026 | — |
| CORAL DRUGS PRIVATE LIMITED New Delhi | IN | CEP 2016-020 - Rev 01 Budesonide | Jan 2026 | — |
| MINAKEM Dunkerque | FR | CEP 2010-190 - Rev 04 Budesonide, Micronised, non-micronised | Dec 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2014-051 - Rev 02 Budesonide, T Process | Jul 2025 | — |
| FERMION OY Espoo | FI | CEP 2025-102 - Rev 00 Budesonide, Process 2B, micronised | May 2025 | Inspected Feb 2026 Finland |
| HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang | CN | CEP 2021-346 - Rev 01 Budesonide | Mar 2025 | — |
| HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou City | CN | CEP 2019-295 - Rev 02 Budesonide, Micronised | Dec 2024 | Inspected Nov 2023 Germany |
| SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai | IN | CEP 2022-210 - Rev 00 Budesonide | Sept 2024 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2018-064 - Rev 01 Budesonide | Aug 2024 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2006-061 - Rev 03 Budesonide | Jun 2024 | — |
| NEWCHEM S.p.A. Milano | IT | R1-CEP 2009-185 - Rev 03 Budesonide, Micronised, non-micronised | Jul 2023 | — |
| ASPEN OSS B.V. Oss | NL | R0-CEP 2021-491 - Rev 01 Budesonide, Budesonide ZS | Feb 2023 | — |
| AARTI PHARMALABS LIMITED Mulund (W), Mumbai | IN | R1-CEP 2006-295 - Rev 04 Budesonide | Oct 2022 | — |
| FARMABIOS S.p.A Gropello Cairoli | IT | R1-CEP 2005-174 - Rev 01 Budesonide, Micronised, grades 21, 22 and 23 | Jul 2017 | — |
| STERLING S.p.A. Solomeo Di Corciano | IT | R1-CEP 2009-057 - Rev 00 Budesonide | Oct 2015 | — |
| INDUSTRIALE CHIMICA S.R.L. Saronno | IT | R1-CEP 2000-152 - Rev 04 Budesonide | Mar 2012 | — |
| TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin | CN | R1-CEP 2000-038 - Rev 04 Budesonide | Dec 2011 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (35 listed products contain Budesonide). The latest listed patent expires 23 Jan 2043. The latest listed exclusivity runs to 9 Feb 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Budesonide is a potent corticosteroid used primarily for its anti-inflammatory properties. It is commonly used in the treatment of asthma, inflammatory bowel diseases, and allergic rhinitis.
Chemical identity
- IUPAC name
- (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
- Canonical SMILES
- CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
- InChIKey
- VOVIALXJUBGFJZ-KWVAZRHASA-N
- Synonyms
- Entocort API, airsupra component budesonide, breztri component budesonide, entocort, entocort ec, eohilia, map-0010, map0010, nsc-757788, ortikos, pulmicort, r01ad05
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Budesonide?
28 organisations hold an active US FDA Type II Drug Master File or a CEP for Budesonide: CURIA SPAIN SAU (Spain), Farmabios S.p.A. (Italy), TAPI NL BV (Netherlands), BREATHGREEN PHARMACEUTICAL CO LTD, AARTI PHARMALABS LIMITED (India), ASPEN OSS BV (Netherlands), Aurisco Pharmaceutical Co.,ltd (China) and Cipla Limited (India), and 20 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Budesonide Drug Master Files are active?
CURIA SPAIN SAU (DMF 25629, 19528), Farmabios S.p.A. (DMF 15298, 25615), TAPI NL BV (DMF 16932, 10976), BREATHGREEN PHARMACEUTICAL CO LTD (DMF 38373, 39691), AARTI PHARMALABS LIMITED (DMF 20609), ASPEN OSS BV (DMF 10493), Aurisco Pharmaceutical Co.,ltd (DMF 41233) and Cipla Limited (DMF 27461) and 17 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Budesonide have a European Certificate of Suitability?
Yes. 20 organisations hold a valid CEP for Budesonide on the EDQM register, including STERLING S.p.A. Corciano (IT), AURISCO PHARMACEUTICAL CO., LTD. Tiantai (CN), CURIA SPAIN S.A.U. Boecillo (ES), AVIK PHARMACEUTICAL LIMITED Vapi (IN), VAMSI LABS LIMITED Solapur (IN) and CORAL DRUGS PRIVATE LIMITED New Delhi (IN) and 15 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Budesonide?
Yes. The latest patent listed for an approved US product containing Budesonide expires 23 Jan 2043, across 35 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Budesonide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Budesonide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.